AGREEMENT AND PLAN OF MERGER among: TURNING POINT THERAPEUTICS, INC., a Delaware corporation; BRISTOL-MYERS SQUIBB COMPANY, a Delaware corporation; and RHUMBA MERGER SUB INC., a Delaware corporation Dated as of June 2, 2022Agreement and Plan of Merger • June 3rd, 2022 • Turning Point Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 3rd, 2022 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER is made and entered into as of June 2, 2022, by and among: BRISTOL-MYERS SQUIBB COMPANY, a Delaware corporation (“Parent”); RHUMBA MERGER SUB INC., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”); and TURNING POINT THERAPEUTICS, INC., a Delaware corporation (the “Company”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
AGREEMENT AND PLAN OF MERGER by and among ONVIA, INC. PROJECT DIAMOND INTERMEDIATE HOLDINGS CORP. PROJECT OLYMPUS MERGER SUB, INC. and solely with respect to Section 9.12 DELTEK, INC. dated as of October 4, 2017Agreement and Plan of Merger • October 5th, 2017 • Onvia Inc • Services-business services, nec • Delaware
Contract Type FiledOctober 5th, 2017 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of October 4, 2017 by and among: (i) Onvia, Inc., a Delaware corporation (the “Company”); (ii) Project Diamond Intermediate Holdings Corp., a Delaware corporation (“Parent”); (iii) Project Olympus Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”) and, solely for the purposes stated in Section 9.12, Deltek, Inc., a Delaware corporation (“Guarantor”). Certain capitalized terms used in this Agreement are defined in Exhibit A.